These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 10910014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC.
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [Abstract] [Full Text] [Related]

  • 3. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B, Palazzo MC, Oldani L, Altamura AC.
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 14():15-8. PubMed ID: 9818626
    [Abstract] [Full Text] [Related]

  • 5. Noradrenergic approaches to antidepressant therapy.
    Gorman JM, Sullivan G.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 1():13-6. PubMed ID: 10703758
    [Abstract] [Full Text] [Related]

  • 6. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 14():11-4. PubMed ID: 9818625
    [Abstract] [Full Text] [Related]

  • 7. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M.
    Acta Psychiatr Scand Suppl; 2000 Dec; 402():28-36. PubMed ID: 10901156
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG.
    J Clin Psychiatry; 1999 Dec; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [Abstract] [Full Text] [Related]

  • 9. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ.
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [Abstract] [Full Text] [Related]

  • 10. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract] [Full Text] [Related]

  • 11. Psychobiology and psychopharmacotherapy of unipolar major depression: a review.
    O'Toole SM, Johnson DA.
    Arch Psychiatr Nurs; 1997 Dec; 11(6):304-13. PubMed ID: 9419922
    [Abstract] [Full Text] [Related]

  • 12. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF.
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [Abstract] [Full Text] [Related]

  • 14. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC, Mazure CM, Jatlow PI, Bowers MB, Price LH.
    Biol Psychiatry; 2004 Feb 01; 55(3):296-300. PubMed ID: 14744472
    [Abstract] [Full Text] [Related]

  • 15. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA.
    Eur Neuropsychopharmacol; 1997 Apr 01; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Eriksson E.
    Acta Psychiatr Scand Suppl; 2000 Apr 01; 402():12-7. PubMed ID: 10901154
    [Abstract] [Full Text] [Related]

  • 17. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK, Eastwood BJ, Need AB, Shannon HE.
    Neuropharmacology; 2006 Dec 01; 51(7-8):1172-80. PubMed ID: 17045620
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
    Frazer A.
    J Clin Psychiatry; 2001 Dec 01; 62 Suppl 12():16-23. PubMed ID: 11430614
    [Abstract] [Full Text] [Related]

  • 19. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P, Bergeron R, de Montigny C.
    Neuropsychopharmacology; 1997 May 01; 16(5):333-8. PubMed ID: 9109104
    [Abstract] [Full Text] [Related]

  • 20. Development of new antidepressants.
    Sambunaris A, Hesselink JK, Pinder R, Panagides J, Stahl SM.
    J Clin Psychiatry; 1997 May 01; 58 Suppl 6():40-53. PubMed ID: 9227672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.